Key result
Female sex is linked to better survival after TAVR versus men despite more early complications.
Why the study?
Outcomes after transcatheter aortic valve replacement based on an individual's sex remain to be fully elucidated.
Do outcomes after transcatheter aortic valve replacement differ between women and men?
Do outcomes after transcatheter aortic valve replacement differ between women and men?
Following TAVR, women appear to have better survival than men but face higher risks of 30-day vascular and bleeding complications, which may be partly explained by differences in baseline comorbidities.
Answers are grounded in this paper and cite their sources.
May support sex-specific TAVR risk discussions; leaves open mechanisms and need for prospective validation.
Transcatheter aortic valve replacement (TAVR) is a safe and effective therapy for aortic valve replacement in patients ineligible for or at high risk for surgery. However, outcomes after TAVR based on an individual's sex remain to be fully elucidated. We searched PUBMED and EMBASE using the keywords: "transcatheter aortic valve replacement," "transcatheter aortic valve implantation," "sex differences," "gender," "sex characteristics" and collected information on baseline features, procedural characteristics, and postprocedural outcomes in women. Inclusion/exclusion resulted in 23 publications. Women had less preexisting comorbidities than men. Most studies reported better survival in women (range of hazard ratio [95% CI] = 0.27 [0.09-0.84] to 0.91 [0.75-1.10]). At 30 days, women also had more vascular complications (6-20% vs 2-14%) and higher bleeding rates (10-44% vs 8-25%). Stroke rates were similar at 30 days (women, 1-7%; men, 1-5%). This literature review showed better survival in women than men after TAVR. However, women had more vascular complications and bleeding; stroke rates were similar. These findings may partly be explained by fewer baseline comorbidities in women. These results should be interpreted with caution as most measures only include unadjusted percentages.
No takes yet. Share an insight, caveat, or question.
Azarbaijani et al. (2017) conducted a review in Aortic valve replacement. Female sex vs. Male sex was evaluated on Survival (HR 0.27 to 0.91, 95% CI 0.09-0.84 to 0.75-1.10). Female sex was associated with better survival after TAVR compared to men, despite higher 30-day rates of vascular complications and bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: